AIP mutation in pituitary adenomas in the 18th century and today.

AIP mutation in pituitary adenomas in the 18th century and today.

Gigantism results when a growth hormone-secreting pituitary adenoma is present before epiphyseal fusion. In 1909, when Harvey Cushing examined the skeleton of an Irish patient who lived from 1761 to 1783, he noted an enlarged pituitary fossa. We extracted DNA from the patient's teeth and identi...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Chahal, H, Stals, K, Unterländer, M, Balding, D, Thomas, MG, Kumar, A, Besser, G, Atkinson, AB, Morrison, P, Howlett, T, Levy, M, Orme, S, Akker, SA, Abel, R, Grossman, AB, Burger, J, Ellard, S, Korbonits, M
التنسيق:	Journal article
اللغة:	English
منشور في:	2011

مواد مشابهة

Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.
حسب: Chahal, H, وآخرون
منشور في: (2011)

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
حسب: Igreja, S, وآخرون
منشور في: (2010)

The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.
حسب: Trivellin, G, وآخرون
منشور في: (2010)

Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
حسب: Preda, V, وآخرون
منشور في: (2014)

Novel molecular aspects of pituitary adenomas.
حسب: Hubina, E, وآخرون
منشور في: (2005)

The pathology of pituitary adenomas from a clinical perspective.
حسب: Dworakowska, D, وآخرون
منشور في: (2011)

Oncogene-induced senescence in pituitary adenomas and carcinomas.
حسب: Alexandraki, K, وآخرون
منشور في: (2012)

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
حسب: Chahal, H, وآخرون
منشور في: (2012)

The pathophysiology of pituitary adenomas.
حسب: Dworakowska, D, وآخرون
منشور في: (2009)

The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
حسب: Lloyd, C, وآخرون
منشور في: (2014)

The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas
حسب: Lloyd, C, وآخرون
منشور في: (2014)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
حسب: Adrian F Daly, وآخرون
منشور في: (2019-03-01)

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
حسب: Chahal, H, وآخرون
منشور في: (2010)

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
حسب: Morris, D, وآخرون
منشور في: (2005)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
حسب: Korbonits, M, وآخرون
منشور في: (2001)

The release of leptin and its effect on hormone release from human pituitary adenomas.
حسب: Korbonits, M, وآخرون
منشور في: (2001)

Akting and cycling: a tale of the pituitary.
حسب: Grossman, AB, وآخرون
منشور في: (2004)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
حسب: Korbonits, M, وآخرون
منشور في: (1998)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members’ View in an AIP Mutation-Positive Family
حسب: Pedro Marques, وآخرون
منشور في: (2018-01-01)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
حسب: Chahal, H, وآخرون
منشور في: (2010)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
حسب: Korbonits, M, وآخرون
منشور في: (1999)

Increased population risk of AIP-related acromegaly and gigantism in Ireland.
حسب: Radian, S, وآخرون
منشور في: (2016)

Metabolic changes in patients with familial pituitary adenomas associated with mutations in the AIP gene
حسب: Tatiana S. Tarasova, وآخرون
منشور في: (2017-03-01)

A mutation and expression analysis of the oncogene BRAF in pituitary adenomas.
حسب: Ewing, I, وآخرون
منشور في: (2007)

MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
حسب: Trivellin, G, وآخرون
منشور في: (2012)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
حسب: Korbonits, M, وآخرون
منشور في: (1995)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
حسب: Chahal, H, وآخرون
منشور في: (2011)

Cyclins and their related proteins in pituitary tumourigenesis.
حسب: Muşat, M, وآخرون
منشور في: (2010)

Second brain tumour after treatment for pituitary adenoma.
حسب: Wass, J, وآخرون
منشور في: (1992)

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
حسب: Morris, D, وآخرون
منشور في: (2003)

Presence of ghrelin in normal and adenomatous human pituitary.
حسب: Korbonits, M, وآخرون
منشور في: (2001)

Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
حسب: Pyle, M, وآخرون
منشور في: (2003)

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
حسب: Igreja, S, وآخرون
منشور في: (2009)

Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.
حسب: Skelly, R, وآخرون
منشور في: (2000)

Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma.
حسب: Allan, C, وآخرون
منشور في: (2001)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
حسب: Korbonits, M, وآخرون
منشور في: (1999)

Role of regulatory factors in pituitary tumour formation.
حسب: Korbonits, M, وآخرون
منشور في: (2004)

Cyclin D and cyclin E expression in normal and adenomatous pituitary.
حسب: Jordan, S, وآخرون
منشور في: (2000)

Cell cycle dysregulation in pituitary oncogenesis.
حسب: Muşat, M, وآخرون
منشور في: (2004)

The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
حسب: Aylwin, S, وآخرون
منشور في: (2001)